Skip to main content

Clinical Trials › NCT06800404

Active, Not RecruitingPhase 2

HB-adMSCs for the Treatment of Patients With Multiple Sclerosis

Sponsored by Hope Biosciences Research Foundation

Interested in joining? Eligibility criteria and contact info are on ClinicalTrials.gov.
View on ClinicalTrials.gov
10
Target enrollment
1
U.S. states
May 2025
Start date
Jan 2027
Expected completion

Interventions / Treatments

Autologous HB-adMSCs

Conditions studied

Relapsing Remitting Multiple Sclerosis (RRMS)Multiple Sclerosis

Where this trial is running (1 site)

Texas1 site
Sugar Land

MS centers in Texas

Compare treatment centers near a trial site by center type, providers and trials.

View Texas centers

More Phase 2 trials

Browse all Phase 2 MS trials
The app

Check out the MS Buddy app

Track symptoms, monitor wellness, and stay on top of your MS care. It’s free, with no ads. Built by people living with MS.

Download on the App StoreGet it on Google Play